LCTX Lineage Cell Therapeutics, Inc.

Fundamentals / CIK 0000876343 / USD

Lineage Cell Therapeutics, Inc. reported $10.84M in revenue and net income of $1.75M for the trailing twelve months ended September 30, 2026 (down 61.0% year over year), with a -280.3% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open LCTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$39.80M$19.90M$0-$62.26MFY 2016 Revenue: $5.92MFY 2016 Net Income: $33.57M2016FY 2017 Revenue: $3.46MFY 2017 Net Income: -$19.98M2017FY 2018 Revenue: $4.99MFY 2018 Net Income: -$45.99M2018FY 2019 Revenue: $3.52MFY 2019 Net Income: -$11.71M2019FY 2020 Revenue: $1.83MFY 2020 Net Income: -$20.65M2020FY 2021 Revenue: $4.34MFY 2021 Net Income: -$43.02M2021FY 2022 Revenue: $14.70MFY 2022 Net Income: -$26.27M2022FY 2023 Revenue: $8.95MFY 2023 Net Income: -$21.49M2023FY 2024 Revenue: $9.50MFY 2024 Net Income: -$18.61M2024FY 2025 Revenue: $14.56MFY 2025 Net Income: -$63.53M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $14.56M $9.50M $8.95M $14.70M $4.34M $1.83M $3.52M $4.99M $3.46M $5.92M
Cost of Revenue -- $334K $671K $728K $1.43M $385K $412K $302K $168K $358K
Gross Profit -- $9.16M $8.27M $13.97M $2.92M $1.44M $3.10M $4.69M $3.29M $5.57M
Research & Development $17.73M $12.47M $15.71M $13.99M $33.91M $12.32M $17.95M $20.95M $24.02M $36.11M
Total Operating Expenses -- -- $33.01M $36.49M $52.13M $27.89M $41.98M $46.48M $43.95M $64.53M
Operating Income -$36.62M -$21.48M -$24.73M -$22.52M -$49.21M -$26.45M -$38.88M -$41.80M -$38.90M -$58.97M
EBITDA -$35.92M -$20.89M -$24.17M -$21.94M -$48.55M -$25.62M -$37.87M -$40.71M -$37.95M -$57.79M
Interest Income -- -- -- -- -- $1.04M $1.69M -- -- --
Income Before Tax -$68.65M -$18.58M -$23.28M -$25.81M -$43.27M -$21.92M -$19.23M -$47.13M -$23.29M $18.62M
Income Tax Expense -$5.28M $0 -$1.80M $541K -- -$1.24M -$7.41M $346K -- --
Net Income -$63.53M -$18.61M -$21.49M -$26.27M -$43.02M -$20.65M -$11.71M -$45.99M -$19.98M $33.57M
Basic EPS -$0.28 -$0.09 -$0.12 -$0.15 -$0.26 -$0.14 -$0.08 -$0.36 -$0.17 $0.35
Diluted EPS -$0.28 -$0.09 -$0.12 -$0.15 -$0.26 -$0.14 -$0.08 -$0.36 -$0.17 $0.34
Basic Shares Outstanding 230.1M 200.2M 172.7M 169.8M 164.5M 150.0K 145.5K 126.9K 114.5M 97.3M
Diluted Shares Outstanding 230.1M 200.2M 172.7M 169.8M 164.5K 150.0K 145.5K 126.9K 114.5M 99.6M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $1.43M $1.07M $1.73M $6.61M $3.68M $2.77M $1.50M $2.87M
Cost of Revenue -- -- -- -- -- -- $36K $154K
Gross Profit -- -- -- -- -- -- $1.47M $2.71M
Research & Development $3.82M $4.77M $4.23M $8.24M $3.27M $3.11M $3.11M $3.42M
Operating Income -$7.31M -$8.92M -$7.59M -$6.55M -$3.79M -$19.78M -$6.50M -$5.11M
EBITDA -$7.11M -$8.74M -$7.41M -$6.36M -$3.61M -$19.61M -$6.34M -$4.96M
Income Before Tax $4.71M -- -- -- -$29.75M -- -- -$3.25M
Income Tax Expense $484K -- -- -- $0 -- -- $0
Net Income $4.23M $1.48M -$4.81M $851K -$29.78M -$30.46M -$4.14M -$3.27M
Basic EPS $0.02 $0.01 -$0.02 -- -$0.13 -$0.13 -$0.02 --
Diluted EPS -$0.03 -$0.03 -$0.03 -- -$0.13 -$0.13 -$0.02 --
Basic Shares Outstanding 252.9M 249.5M 245.0M -- 228.9M 228.4M 226.1M --
Diluted Shares Outstanding 259.1M 261.5M 261.2M -- 228.9M 228.4M 226.1M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $40.79M $45.79M $35.44M $11.36M $55.74M $32.59M $9.50M $23.59M $36.84M $22.09M
Short-Term Investments $14.99M $2.02M $50K $46.52M $2.62M $8.98M $21.22M $7.15M $1.34M --
Cash & Short-Term Investments $55.78M $47.80M $35.49M $57.88M $58.40M $41.60M $30.70M $30.70M $38.20M $12.50M
Accounts Receivable, Net $891K $638K $745K $297K $50.60M $242K $44K $51K $139K $344K
Total Current Assets $59.16M $51.00M $38.44M $60.00M $111.5M $44.00M $57.52M $36.36M $42.62M $25.65M
Property, Plant & Equipment, Net $2.57M $2.25M $2.25M $5.67M $4.87M $5.63M $8.18M $5.83M $5.53M $5.53M
Goodwill $10.67M $10.67M $10.67M $10.67M $10.67M $10.67M $10.67M -- -- --
Intangible Assets $31.70M $46.54M $46.56M $46.69M $46.82M $47.03M $48.25M $3.12M $6.90M $10.21M
Total Non-Current Assets $53.43M $62.22M $62.58M $63.66M $63.00M $63.95M $67.96M $65.30M $130.6M $116.9M
Total Assets $112.6M $113.2M $101.0M $123.7M $174.5M $107.9M $125.5M $101.7M $173.2M $142.6M
Accounts Payable $2.34M $1.17M $2.05M $2.39M $3.54M $2.61M $2.43M $2.36M $938K $1.59M
Deferred Revenue (Current) $3.33M $7.39M $10.80M $9.40M $52.10M $193K $45K $42K $309K $572K
Total Current Liabilities $11.37M $13.98M $17.96M $18.98M $47.12M $7.77M $6.49M $6.81M $6.88M $8.85M
Deferred Revenue (Non-Current) $12.38M $14.43M $18.69M $27.73M $32.45M -- $200K $3.50M -- $308K
Other Non-Current Liabilities -- -- $0 $2.0K $30K -- -- -- -- $8.0K
Total Non-Current Liabilities $57.87M $22.23M $21.04M $32.75M $36.53M $5.05M $7.74M $2.60M $2.10M $3.21M
Total Liabilities $69.24M $36.21M $39.00M $51.73M $83.65M $12.82M $14.23M $9.41M $8.98M $12.06M
Total Debt (incl. Leases) $2.42M $2.51M $2.95M $3.90M $2.80M $284K $942K $2.19M -- --
Common Stock $515.5M $484.7M $451.3M $440.3M $434.5M $393.9M $387.1M $354.3M $378.5M $317.9M
Retained Earnings -$467.0M -$403.5M -$384.9M -$363.4M -$337.1M -$294.1M -$273.4M -$261.9M -$216.3M -$196.3M
Accumulated Other Comp. Income -$3.92M -$2.88M -$3.07M -$3.57M -$5.21M -$3.67M -$681K $1.43M $451K -$738K
Total Stockholders' Equity $44.55M $78.38M $63.42M $73.34M $92.22M $96.20M $113.0M $92.25M $162.6M $117.9M
Total Equity $43.35M $77.01M $62.02M $71.94M $90.90M $95.13M $111.2M $92.25M $164.3M $130.5M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $26.50M $37.35M $35.94M $40.79M $40.46M $42.27M $47.89M $45.79M
Short-Term Investments $18.68M $13.47M $17.44M $14.99M $23K $17K $19K $2.02M
Cash & Short-Term Investments $45.18M $50.83M $53.38M $55.78M $40.49M $42.29M $47.91M $47.80M
Accounts Receivable, Net $1.33M $790K $806K $891K $127K $256K $213K $638K
Total Current Assets $47.77M $52.97M $56.16M $59.16M $42.26M $43.84M $49.98M $51.00M
Property, Plant & Equipment, Net $2.38M $2.52M $2.50M $2.57M $2.16M $2.25M $2.15M $2.25M
Goodwill $10.67M $10.67M $10.67M $10.67M $10.67M $10.67M $10.67M $10.67M
Intangible Assets $31.70M $31.70M $31.70M $31.70M $31.70M $31.70M $46.54M $46.54M
Total Non-Current Assets $52.34M $53.25M $53.37M $53.43M $47.38M $46.95M $61.77M $62.22M
Total Assets $100.1M $106.2M $109.5M $112.6M $89.64M $90.80M $111.8M $113.2M
Accounts Payable $1.64M $1.54M $1.59M $2.34M $1.52M $1.50M $2.00M $1.17M
Deferred Revenue (Current) $1.42M $1.68M $1.72M $3.33M $3.77M $5.26M $6.93M $7.39M
Total Current Liabilities $8.02M $8.02M $8.15M $11.37M $9.38M $10.76M $13.09M $13.98M
Deferred Revenue (Non-Current) $12.34M $12.34M $13.00M $12.38M $12.46M $12.75M $13.61M $14.43M
Total Non-Current Liabilities $26.15M $38.41M $48.69M $57.87M $59.46M $32.93M $21.01M $22.23M
Total Liabilities $34.17M $46.42M $56.84M $69.24M $68.84M $43.69M $34.10M $36.21M
Total Debt (incl. Leases) $2.03M $2.30M $2.39M $2.42M $2.62M $2.15M $2.24M $2.51M
Common Stock $537.4M $535.7M $529.7M $515.5M $494.2M $490.6M $489.3M $484.7M
Retained Earnings -$466.1M -$470.3M -$471.8M -$467.0M -$467.8M -$438.1M -$407.6M -$403.5M
Accumulated Other Comp. Income -$4.26M -$4.47M -$3.97M -$3.92M -$4.29M -$4.10M -$2.68M -$2.88M
Total Stockholders' Equity $67.06M $60.92M $53.88M $44.55M $22.04M $48.38M $79.03M $78.38M
Total Equity $65.94M $59.80M $52.70M $43.35M $20.80M $47.11M $77.66M $77.01M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$63.37M -$18.58M -$21.48M -$26.35M -$43.27M -$20.68M -$11.83M -$46.78M -$23.29M $18.62M
Depreciation & Amortization $699K $587K $562K $582K $663K $823K $1.00M $1.08M $947K $1.18M
Stock-Based Compensation $4.75M $5.08M $4.64M $4.29M $3.52M $2.23M $3.58M $5.40M $3.93M $7.95M
Change in Working Capital -- -- -- -- -- -- -- -$487K -$22K $56K
Change in Receivables -$316K $106K -$446K $50.31M -$857K $287K $467K $46K -$172K $187K
Change in Inventory -- -- -- -- -- -- -- -- -- $0
Operating Cash Flow -$18.92M -$23.09M -$28.57M $1.06M -$23.56M -$19.75M -$31.95M -$30.88M -$30.52M -$42.33M
Capital Expenditure -$522K -$565K -$674K -$413K -$340K -$64K -$440K -$556K -$1.33M -$2.25M
Free Cash Flow -$19.44M -$23.66M -$29.24M $646K -$23.90M -$19.82M -$32.39M -$31.44M -$31.84M -$44.57M
Purchases of Investments -$14.94M -$8.76M -$16.40M -$53.41M -- -- -- -- -- --
Investing Cash Flow -$13.46M -$2.31M $46.45M -$46.16M $9.74M $13.04M $16.96M $11.82M -$10.22M -$10.89M
Common Stock Issued -- -- $6.62M $148K $30.86M $5.13M $103K -- $48.88M $20.12M
Financing Cash Flow $26.95M $35.86M $6.42M $1.63M $36.93M $29.86M $617K $5.77M $55.39M $32.78M
Net Change in Cash -$5.03M $10.36M $24.06M -$44.34M $23.09M $23.09M -$14.30M -$13.29M $14.75M -$20.14M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $4.23M $1.54M -$4.79M $892K -$29.75M -$30.36M -$4.14M -$3.25M
Depreciation & Amortization $202K $187K $188K $186K $178K $171K $164K $151K
Stock-Based Compensation $1.70M $1.60M $1.17M $1.10M $1.20M $1.24M $1.22M $1.31M
Change in Receivables -$544K $19K $154K -$827K $130K -$43K $424K -$233K
Operating Cash Flow -$5.62M -$7.24M -$8.08M -$4.88M -$3.62M -$5.54M -$4.89M -$6.35M
Capital Expenditure -$74K -$108K -$55K -$399K -$12K -$14K -$97K -$365K
Free Cash Flow -$5.69M -$7.35M -$8.13M -$5.28M -$3.63M -$5.55M -$4.98M -$6.71M
Purchases of Investments -$11.13M -$10.43M -$8.24M -$14.94M $0 $0 $0 $0
Investing Cash Flow -$5.15M $3.96M -$2.33M -$15.33M -$12K -$14K $1.90M $2.63M
Financing Cash Flow -$23K $4.47M $5.56M $20.38M $1.83M -$307K $5.04M $21.73M
Net Change in Cash -$10.87M $1.44M -$4.85M $347K -$1.80M -$5.57M $1.99M $18.05M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- 96.5% 92.5% 95.0% 67.2% 78.9% 88.3% 93.9% 95.1% 94.0%
Operating Margin -251.6% -226.1% -276.5% -153.2% -1133.6% -1448.4% -1106.0% -837.9% -1125.0% -995.6%
Net Profit Margin -436.5% -195.9% -240.2% -178.7% -991.0% -1130.8% -333.1% -922.0% -577.7% 566.8%
Return on Equity (ROE) -142.6% -23.7% -33.9% -35.8% -46.6% -21.5% -10.4% -49.9% -12.3% 28.5%
Return on Assets (ROA) -56.4% -16.4% -21.3% -21.2% -24.6% -19.1% -9.3% -45.2% -11.5% 23.5%
Current Ratio 5.20x 3.65x 2.14x 3.16x 2.37x 5.66x 8.86x 5.34x 6.20x 2.90x
Quick Ratio 4.99x 3.47x 2.02x 3.06x 2.31x 5.39x 4.73x 4.51x 5.57x 1.45x
Debt to Equity 0.05x 0.03x 0.05x 0.05x 0.03x 0.00x 0.01x 0.02x -- --
Revenue Growth (YoY) +53.2% +6.2% -39.2% +238.7% +137.7% -48.1% -29.5% +44.2% -41.6% -15.8%
Gross Profit Growth (YoY) -- +10.8% -40.8% +379.4% +102.3% -53.6% -33.8% +42.4% -40.9% -6.1%
Net Income Growth (YoY) -- -- -- -- -- -- -- -- -159.5% --
EPS Growth (YoY) -- -- -- -- -- -- -- -- -148.6% --
Operating Cash Flow Growth (YoY) -- -- -2797.5% -- -- -- -- -- -- --
Free Cash Flow Growth (YoY) -- -- -4626.3% -- -- -- -- -- -- --
5Y Revenue / Share Growth -99.5% -99.8% -99.9% +186.7% -56.6% +13687.2% +30513.1% +47969.1% -62.0% -35.4%
10Y Revenue / Share Growth -28.3% -39.9% -36.6% +8.8% -72.0% +13115.5% -- -- -- --
5Y Net Income / Share Growth -- -- -- -- -175.8% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin -- -- -- -- -- -- 97.2% 96.5%
Operating Margin -280.3% -205.2% -255.1% -251.6% -325.3% -322.8% -223.1% -226.1%
Net Profit Margin 16.2% -246.6% -434.4% -436.5% -625.5% -374.8% -169.6% -195.9%
Return on Equity (ROE) 2.6% -53.0% -119.2% -142.6% -307.0% -84.6% -20.5% -23.7%
Return on Assets (ROA) 1.8% -30.4% -58.6% -56.4% -75.5% -45.1% -14.5% -16.4%
Current Ratio 5.96x 6.61x 6.89x 5.20x 4.50x 4.08x 3.82x 3.65x
Quick Ratio 5.80x 6.44x 6.65x 4.99x 4.33x 3.96x 3.68x 3.47x
Debt to Equity 0.03x 0.04x 0.04x 0.05x 0.12x 0.04x 0.03x 0.03x
Revenue Growth (YoY) -61.0% -61.3% +14.8% +130.4% -2.6% +96.4% +4.0% +37.4%
Gross Profit Growth (YoY) -- -- -- -- -- -- +8.9% +48.1%
Source: SEC EDGAR CompanyFacts (CIK 0000876343) · from December 31, 2009 Data through September 30, 2026 · synced Nov 20, 2026, 05:42 UTC · Open in terminal